Author Archives: claire gallagher

SPARK Impact investee company to collaborate with AstraZeneca

One of SPARK Impact’s investee companies has announced a pioneering new research collaboration agreement with AstraZeneca. Molplex Pharmaceuticals is a drug discovery company…
Continue reading

Clinical trial success for Spark Impact back pain relief product

  Liverpool based LumbaCurve International, backed by SPARK Impact, manager of The North West Fund for Biomedical, have announced that clinical trials of…
Continue reading